Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
-
- Manisha H. Shah
- 1The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;
-
- Whitney S. Goldner
- 2Fred & Pamela Buffett Cancer Center;
-
- Al B. Benson
- 3Robert H. Lurie Comprehensive Cancer Center of Northwestern University;
-
- Emily Bergsland
- 4UCSF Helen Diller Family Comprehensive Cancer Center;
-
- Lawrence S. Blaszkowsky
- 5Massachusetts General Hospital Cancer Center;
-
- Pamela Brock
- 1The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;
-
- Jennifer Chan
- 6Dana-Farber/Brigham and Women’s Cancer Center;
-
- Satya Das
- 7Vanderbilt-Ingram Cancer Center;
-
- Paxton V. Dickson
- 8St. Jude Children's Research Hospital/The University of Tennessee Health Science Center;
-
- Paul Fanta
- 9UC San Diego Moores Cancer Center;
-
- Thomas Giordano
- 10University of Michigan Rogel Cancer Center;
-
- Thorvardur R. Halfdanarson
- 11Mayo Clinic Cancer Center;
-
- Daniel Halperin
- 12The University of Texas MD Anderson Cancer Center;
-
- Jin He
- 13The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;
-
- Anthony Heaney
- 14UCLA Jonsson Comprehensive Cancer Center;
-
- Martin J. Heslin
- 15O'Neal Comprehensive Cancer Center at UAB;
-
- Fouad Kandeel
- 16City of Hope National Medical Center;
-
- Arash Kardan
- 17Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;
-
- Sajid A. Khan
- 18Yale Cancer Center/Smilow Cancer Hospital;
-
- Boris W. Kuvshinoff
- 19Roswell Park Comprehensive Cancer Center;
-
- Christopher Lieu
- 20University of Colorado Cancer Center;
-
- Kimberly Miller
- 2Fred & Pamela Buffett Cancer Center;
-
- Venu G. Pillarisetty
- 21Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;
-
- Diane Reidy
- 22Memorial Sloan Kettering Cancer Center;
-
- Sarimar Agosto Salgado
- 23UT Southwestern Simmons Comprehensive Cancer Center;
-
- Shagufta Shaheen
- 24Stanford Cancer Institute;
-
- Heloisa P. Soares
- 25Huntsman Cancer Institute at the University of Utah;
-
- Michael C. Soulen
- 26Abramson Cancer Center at the University of Pennsylvania;
-
- Jonathan R. Strosberg
- 27Moffitt Cancer Center;
-
- Craig R. Sussman
- 7Vanderbilt-Ingram Cancer Center;
-
- Nikolaos A. Trikalinos
- 28Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;
-
- Nataliya A. Uboha
- 29University of Wisconsin Carbone Cancer Center;
-
- Namrata Vijayvergia
- 30Fox Chase Cancer Center;
-
- Terence Wong
- 31Duke Cancer Institute; and
-
- Beth Lynn
- 32National Comprehensive Cancer Network;
-
- Cindy Hochstetler
- 32National Comprehensive Cancer Network;
説明
<jats:p>The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas, paragangliomas, and multiple endocrine neoplasia. NETs are generally subclassified by site of origin, stage, and histologic characteristics. Appropriate diagnosis and treatment of NETs often involves collaboration between specialists in multiple disciplines, using specific biochemical, radiologic, and surgical methods. Specialists include pathologists, endocrinologists, radiologists (including nuclear medicine specialists), and medical, radiation, and surgical oncologists. These guidelines discuss the diagnosis and management of both sporadic and hereditary neuroendocrine and adrenal tumors and are intended to assist with clinical decision-making. This article is focused on the 2021 NCCN Guidelines principles of genetic risk assessment and counseling and recommendations for well-differentiated grade 3 NETs, poorly differentiated neuroendocrine carcinomas, adrenal tumors, pheochromocytomas, and paragangliomas.</jats:p>
収録刊行物
-
- Journal of the National Comprehensive Cancer Network
-
Journal of the National Comprehensive Cancer Network 19 (7), 839-868, 2021-07
Harborside Press, LLC